US Patent Issued to InTrance Medical Systems on March 18 for "Continuous administration of pharmaceutical composition for treatment of neurodegenerative disorders" (Swedish Inventor)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,251,368, issued on March 18, was assigned to InTrance Medical Systems Inc. (New York).

"Continuous administration of pharmaceutical composition for treatment of neurodegenerative disorders" was invented by Roger Bolsoy (Uppsala, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating patients by using a pharmaceutical composition for intra-intestinal administration comprises (i) a dopamine replacement agents, (ii) a dopamine decarboxylase inhibitor (DDI), and (iii) a COMT inhibitor where the composition is continuously administered."

The patent was filed on Nov. 4, 2022, under Application No. 17/981,092.

*For further information, i...